ホーム > 穂積 康夫/ Hozumi, Yasuo

穂積 康夫

ALUMNI 2025年11月現在、筑波大学が主たる所属機関ではありません

Hozumi, Yasuo

医学医療系 , 教授
Faculty of Medicine , Professor

関連記事はまだありません。

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. 乳癌転移に伴う水腎症に対し積極的介入を行った8症例の検討 藤原, 彩織; 坂東, 裕子; 上田, 文; 市岡恵美香 (+3 著者) 原, 尚人
      乳癌の臨床 36: 295 (2021)
  2. 2. The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial Yamaguchi, Takeshi; Hozumi, Yasuo; Sagara, Yasuaki; Takahashi, Masato (+7 著者) Mukai, Hirofumi
      Surgical oncology 36: 51 (2021) Semantic Scholar
  3. 3. A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study Takashima, Tsutomu; Hara, Fumikata; Iwamoto, Takayuki; Uemura, Yukari (+12 著者) Mukai, Hirofumi
      Clinical breast cancer 21: 450 (2021) Semantic Scholar
  4. 4. Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials Noordhoek, Iris; Blok, Erik J; Meershoek-Klein Kranenbarg, Elma; Putter, Hein (+17 著者) Liefers, Gerrit-Jan
      Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38: 3273 (2020) Semantic Scholar
  5. 5. Invasive Cancer Confined to the Nipple of the Conserved Breast: A Case Report Kitahara, Miyuki; Hozumi, Yasuo; Takeuchi, Naoto; Ichinohe, Satoko (+1 著者) Iijima, Tatsuo
      Case reports in oncology 13: 1125 (2020) Semantic Scholar
  6. 6. Distant Metastasis after Surgery for Encapsulated Papillary Carcinoma of the Breast: A Case Report Kitahara, Miyuki; Hozumi, Yasuo; Takeuchi, Naoto; Ichinohe, Satoko (+3 著者) Iijima, Tatsuo
      Case reports in oncology 13: 1196 (2020) Semantic Scholar
  7. 7. Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer Ohsumi, Shozo; Mukai, Hirofumi; Takahashi, Masato; Hozumi, Yasuo (+7 著者) Ohashi, Yasuo
      Japanese journal of clinical oncology 50: 873 (2020) Semantic Scholar
  8. 8. Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy Yamashita, Satoshi; Hattori, Naoko; Fujii, Satoshi; Yamaguchi, Takeshi (+9 著者) Mukai, Hirofumi
      Scientific reports 10: (2020) Semantic Scholar
  9. 9. Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study Mukai, Hirofumi; Yamaguchi, Takeshi; Takahashi, Masato; Hozumi, Yasuo (+12 著者) Uemura, Yukari
      British journal of cancer 122: 1747 (2020) Semantic Scholar
  10. 10. Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer Matsunuma, Ryoichi; Watanabe, Toru; Hozumi, Yasuo; Koizumi, Kei (+6 著者) Shiiya, Norihiko
      Breast cancer (Tokyo, Japan) 2020: 819 (2020) Semantic Scholar
  11. 11. Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study Ohno, Shinji; Mukai, Hirofumi; Narui, Kazutaka; Hozumi, Yasuo (+11 著者) Ohashi, Yasuo
      BREAST CANCER RESEARCH AND TREATMENT 176: 631 (2019) Semantic Scholar
  12. 12. HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer Kitahara, Miyuki; Hozumi, Yasuo; Nakamura, Ayaka; Tachi, Kana (+1 著者) Iijima, Tatsuo
      Case reports in oncology 12: 473 (2019) Semantic Scholar
  13. 13. HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer Kitahara, Miyuki; Hozumi, Yasuo; Nakamura, Ayaka; Tachi, Kana (+1 著者) Iijima, Tatsuo
      Case reports in oncology 12: 473 - 479 (2019) Semantic Scholar
  14. 14. Evaluation of oral S-1 as a first-line chemotherapy for metastatic HER2-negative breast cancer: An analysis of two randomized phase III studies (SELECT BC-CONFIRM and SELECT BC) Nishimura, Reiki; Mukai, Hirofumi; Uemura, Yukari; Akabane, Hiromitsu (+7 著者) Watanabe, Takanori
      JOURNAL OF CLINICAL ONCOLOGY 37: (2019) Semantic Scholar
  15. 15. A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS) Ohtani, S; Iijima, K; Higaki, K; Sato, Y (+14 著者) Iwase, T
      CANCER RESEARCH 79: (2019) Semantic Scholar
  16. 16. Randomized phase 3 study of anthracycline-containing regimens versus S-1 as first-line treatment for metastatic breast cancer (SELECT BC-CONFIRM)-A combined analysis of two randomized phase 3 studies (SELECT BC-CONFIRM and SELECT BC)- Park, Y; Akabane, H; Watanabe, T; Takahashi, M (+7 著者) Mukai, H
      CANCER RESEARCH 79: (2019) Semantic Scholar
  17. 17. Bowen's Disease of the Nipple Kitahara, Miyuki; Hozumi, Yasuo; Watanabe, Akie; Iijima, Tatsuo
      Case reports in oncology 11: 609 (2018) Semantic Scholar
  18. 18. Intramammary Metastasis in a Patient with a History of Renal Cell Carcinoma: A Case Report Kitahara, Miyuki; Hozumi, Yasuo; Asada, Rio; Sawa, Aya (+1 著者) Iijima, Tatsuo
      Case reports in oncology 11: 318 (2018) Semantic Scholar
  19. 19. Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial Takeru Shiroiwa; Takashi Fukuda; Kojiro Shimozuma; Mitsuko Mouri (+6 著者) Hirofumi Mukai
      BMC CANCER 17: 773 (2017) Semantic Scholar
  20. 20. 乳癌術前化学療法後の病理学的完全奏功予測の評価 寺崎 梓; Bando, Hiroko; 高木理央; 星 葵 (+7 著者) 原 尚人
      第25回日本乳癌学会学術総会プログラム・抄録集 (2017)
1 2
  1. 1. オンコロジークリニカルガイド 乳癌薬物療法 改訂2版 Hozumi, Yasuo (担当:分担執筆, 範囲:術後内分泌療法 投与期間)
    南山堂 2016年11月 (ISBN: 9784525424428)

 1,076 total views